FDA Watch: FDA Approves Enhanced Cologuard Cancer Test
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
Keeps You Up-to-Date on Federal & State Laws, Regulations, New Legislation, and Court Cases that Affect Your Diagnostic Lab or Pathology Practice
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
Unsurprisingly, the American Hospital Association and other industry groups don’t think that increase is anywhere near adequate.
UDT false billing cases seem to be on the rise again, accounting for a trio of recent multimillion dollar settlements.
On April 11, the OIG approved a proposed arrangement involving the offering of free genetic tests and counseling services.
Counterfeit COVID-19 tests are being illegally imported into the US and being distributed to unsuspecting consumers across the country.
A briefing on how labs should prepare for the inevitable end of the PHE after more than two years of unprecedented relief.
MFCU enforcement activity has rebounded from recent declines but still hasn’t reached pre-pandemic levels, according to a recent OIG report.
Thanks to recent federal enforcement initiatives, prompt response to patient PHI requests should be a growing priority for HIPAA compliance.
This month’s roundup includes the continued court battle between BGI and Illumina, an FCA lawsuit, and the latest version of OSHA’s COVID-19 rule.
Company involved in recent Class 1 recalls of COVID-19 rapid tests now faces further fallout by not refunding customers for faulty tests.
Starting April 4, Medicare beneficiaries can get eight free tests per month for each month the public health emergency remains in effect.